drugset / Trial / NCT02951845

Study to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076 in Healthy Participants

NCT02951845 ↗

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to assess the oral bioavailability of the two tablet formulations of JNJ-54416076 relative to the suspension formulation and to investigate the effect of a high fat meal on the pharmacokinetics of the tablet formulation in healthy participants.

Timeline

Start
2016-11-22
Primary completion
2017-02-17
Completion
2017-02-17

Outcome

Outcome not reported

Stopped (Business): “JNJ-54416076 program has been stopped for strategic business reasons.”

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-54416076 Unknown 25 mg Oral

Indications

No indication recorded.